HFS
MIRM icon

Hantz Financial Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Hantz Financial Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed – – 1193
2024
Q1 		$0 Hold
5
– – ﹤0.01% 1261
2023
Q4 		$0 Hold
5
– – ﹤0.01% 1192
2023
Q3 		$0 Hold
5
– – ﹤0.01% 1162
2023
Q2 		$0 Hold
5
– – ﹤0.01% 1144
2023
Q1 		$0 Hold
5
– – ﹤0.01% 1170
2022
Q4 		$0 Sell
5
-14,963
-100% -$296K ﹤0.01% 1129
2022
Q3 		$314K Buy
14,968
+152
+1% +$3.66K 0.01% 478
2022
Q2 		$288K Buy
14,816
+1,528
+11% +$36K 0.01% 483
2022
Q1 		$293K Buy
13,288
+1,912
+17% +$39K 0.01% 492
2021
Q4 		$181K Buy
+11,376
New +$177K 0.01% 513

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hantz Financial Services's MIRM Position: Q2 2024 in Review

Hantz Financial Services sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 5 shares.

Hantz Financial Services first reported a position in MIRM in Q4 2021 and held it in 10 quarters. The position peaked at $314K in Q3 2022. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

  • Hantz Financial Services reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Hantz Financial Services sold 5 Mirum Pharmaceuticals shares in Q2 2024.
  • Hantz Financial Services first reported a position in Mirum Pharmaceuticals in Q4 2021 and held it in 10 quarters.
  • Hantz Financial Services's Mirum Pharmaceuticals position peaked at $314K in Q3 2022.
  • 160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on Hantz Financial Services's 13F filing for Q2 2024, filed 30 Jul 2024.